Ketamine Infusions May Be Effective for Refractory Headache
For many patients with refractory headache, ketamine treatment may provide short-term analgesia with tolerable adverse events.
For many patients with refractory headache, ketamine treatment may provide short-term analgesia with tolerable adverse events.
A panel of experts formulated consensus guidelines for physicians who use intravenous ketamine infusions to treat chronic pain.
Consensus guidelines regarding the use of ketamine for the management of acute pain have been approved.
Ketamine infusion may provide short-term pain relief for patients with complex regional pain syndrome.
Acute pain management in the emergency department with low-dose ketamine may provide pain relief comparable with morphine at 30 minutes.
Current evidence suggests ketamine may be an effective therapy for the management of chronic noncancer pain.
Ketamine is associated with significant pain relief among patients with refractory headaches.
Ketamine was found to alleviate several pain modalities, and a number of clinical trials investigating its efficacy are ongoing.
Ketamine may alleviate depression, pain, and adverse effects associated with opioid treatment, and may thus represent an attractive adjunct therapy for pain management.
A ketamine regimen is superior to methadone, or ketamine combined with methadone, in alleviating neuropathic pain and associated sensory changes.